Fast Track To Personalized Therapy

neoGMP® Service

neoGMP® produces unique plasmid DNA for each patient at a small scale, compared to a single, large-scale lot for many patients. The service supports the requirements for rapid production from a patient-specific sequence while maintaining the high quality you expect from Aldevron.

Plasmid DNA in Neoantigen Therapy-2


Features of neoGMP®

  • Rapid turnaround
  • Single-use, product-dedicated materials and equipment
  • Options for parallel processing
  • Quality oversight of key processes and parameters
  • Segregated manufacturing

► Download the neoGMP Service Flyer

Aldevron Advantage

  • 22+ year track record in DNA manufacturing
  • Regulatory experience
  • Process optimization expertise
  • Investments in manufacturing process development

neoGMP® Resources

GMP-S Gene Synthesis

Designed to meet the needs of rapid clinical gene synthesis for novel cancer treatments based on neoantigens.
Learn more about our GMP-Source® Gene Synthesis Service.

Press Release

Aldevron has experience bringing neoantigen vaccines to the commercial market.
Learn more about our collaboration with Ziopharm Oncology. 

Connect with an Expert

Connect with us to learn more about how our neoGMP® service can be customized to fit your specific neoantigen projects.
Connect with one of our neoGMP experts to discuss your project.